Purchase Order 36C24925P0570
Award Date
6/4/25
Potential Completion Date
9/30/25
Potential Value
$8.5K
Federal Agency
Veterans Integrated Service Network 9
Awardee
Accredo Health Group, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bartlett, TN 38134, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Veterans Affairs (VA) awarded a $10,708.63 firm fixed-price purchase order to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, for the emergency procurement of the specialty medication Lumryz (sodium oxybate). The contract has an ultimate completion date of May 9, 2025 and does not utilize a set-aside designation. Accredo Health Group, Inc. is a subsidiary of Express Scripts and specializes in providing specialty pharmaceutical services and...
This is a firm fixed-price purchase order award from the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Accredo Health Group, Inc., a for-profit pharmaceutical distribution company. The $38,493.36 contract is for the delivery of LUMRYZ 9GM/PKT (sodium oxybate), a specialty medication, to support the VHA's integrated healthcare networks. As a prime contractor, Accredo regularly fulfills purchase orders and multi-year contracts with the VA to supply specialty...
This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs' Veterans Integrated Service Network 20 (VISN 20) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract, valued at $128,503.56, is for a bulk order of the specialty pharmaceutical Lumryz. As a prime contractor, Accredo Health Group, Inc. has a history of providing specialized medications to the VA's VISNs, with a focus on drugs treating conditions such as pulmonary...
This is a federal contract award from the Veterans Integrated Service Network 20 (VISN 20), a civilian agency, to the prime contractor Accredo Health Group, Inc. The contract is for the purchase of LUMRYX 7.5G, a pharmaceutical product, with a firm fixed price of $40,091.73 and a completion date of September 30, 2025. The contract does not have a set-aside designation. Accredo Health Group, Inc. is a for-profit pharmacy benefit management company based in Memphis, Tennessee, and a subsidiary...
This federal contract award is for the purchase of specialty medications by the U.S. Department of Veterans Affairs (VA) from Accredo Health Group, Inc., a specialty pharmacy services provider. The contract award, valued at $2,603.79, is for the delivery of specific high-value medications to VA medical centers and facilities nationwide, supporting the Veterans Health Administration's (VHA) treatment programs. The contract is a firm fixed-price purchase order with no set-aside designation....
The U.S. Department of Veterans Affairs (VA) awarded a $81,342.18 firm fixed-price purchase order contract to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, to provide the specialty pharmaceutical TYVASO. The contract, which does not have a set-aside designation, is to support the VA's Veterans Integrated Service Network 21 (VISN 21) and has an ultimate completion date of September 30, 2022. Accredo Health Group, Inc. is a key distributor of complex and...
This federal contract award, valued at $80,409.58, was issued by the Department of Veterans Affairs' Veterans Integrated Service Network 19 (VISN 19) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company and subsidiary of Express Scripts. The contract is a firm fixed-price purchase order for the delivery of 9 pharmacy orders across multiple VISN locations, including medications to treat conditions such as pulmonary arterial hypertension, neuropathic lysosomal storage...
This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, for the delivery of the specialty pharmaceutical DUOPA. The $10,122.32 contract has a completion date of May 7, 2025 and was awarded on February 7, 2025 with no set-aside designation. Accredo Health Group, Inc., a subsidiary of Express Scripts, is a key distributor of complex and high-value medications, primarily...
This is a $40,697.68 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract is for the supply of specialty pharmaceutical products, including medications to treat pulmonary arterial hypertension, neuropathic lysosomal storage disorders, and ophthalmic disorders. The contract has an ultimate completion date of March 14, 2025 and is part of the VA's Veterans...
This is a $103,003.20 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company specializing in specialty pharmaceutical services. The contract is for the delivery of various complex and high-value medications, primarily to support the VA's Veterans Integrated Service Network (VISN) healthcare facilities. Key medications provided under this contract include drugs used to treat...